CNC vs UNH: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CNC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CNC and UNH share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CNC and UNH exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Centene Corporation is a St. Louis-based managed-care organization that administers government-sponsored and subsidized health insurance. It is the largest Medicaid managed-care company in the country (roughly 12.5 million members across about 30 states), the top carrier on the Affordable Care Act Marketplace (around 5.5 million members), and a meaningful Medicare player with about 1.0 million Medicare Advantage members plus roughly 8.1 million prescription-drug-plan members. The company reported total revenue of about $194.8 billion in 2025, and the vast majority of that flows from Medicaid, Marketplace (commercial), and Medicare premiums, making Centene highly exposed to federal and state healthcare policy, reimbursement rates, and medical cost trends.

Full CNC guide

UnitedHealth Group is the largest US health insurer and one of the largest healthcare companies in the world. It runs through two main engines. UnitedHealthcare is the insurance arm, providing employer, individual, Medicare Advantage, and Medicaid health plans to tens of millions of members. Optum is the faster-growing health-services arm: Optum Health (physician groups and care delivery, including value-based care), Optum Insight (healthcare data, analytics, and technology), and Optum Rx (one of the largest pharmacy benefit managers in the country). The combination lets UnitedHealth manage both the financing and the delivery of care, capturing margin across the system and using vast claims data to manage costs. Headquartered in Minnetonka, Minnesota, UnitedHealth is a Dow component and one of the largest companies in the S&P 500 by revenue. Its scale, vertical integration, and Medicare Advantage leadership define its competitive position.

Full UNH guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CNC drivers: Medicaid scale and margin recovery; Marketplace leadership and repricing.
• UNH drivers: Optum growth engine; Medicare Advantage scale.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Centene withdrew its 2025 guidance and its stock fell roughly 40% in a single day in July 2025 after actuaries flagged that its ACA Marketplace assumptions were too aggressive, so guidance credibility and forecasting accuracy are live concerns. For UNH, unitedHealth faces a difficult medical-cost environment: rising utilization (especially in Medicare Advantage) can spike the medical loss ratio and compress margins, as the company has experienced.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CNC if you believe its drivers more; UNH if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CNC and UNH guides.

CNC. Centene trades on a low earnings multiple relative to higher-margin managed-care peers, reflecting a depressed post-2025 earnings base and elevated uncertainty. Revenue is enormous (near $195 billion) but health insurance is a thin-margin business, so small changes in the health-benefits ratio move earnings sharply. The 2026 consensus EPS sits near the mid-$3 range.

UNH. UnitedHealth's revenue is enormous but its insurance margins are thin by design, so earnings hinge on the medical loss ratio and Optum's higher-margin growth. The valuation reflects scale and integration but has been pressured by cost inflation, regulatory uncertainty, and reputational headwinds. The market weighs Optum's durable growth against insurance-cycle and political risk.

Headline figures (approximate, July 2026): CNC shows revenue (2025) ~$194.8B, 2026 revenue guidance ~$187.5B to $191.5B, q1 2026 adjusted eps ~$3.37, 2026 adjusted eps guidance ~>$3.40; UNH shows revenue (ttm) ~$400 billion, operating margin ~6-8%, net income (ttm) ~$15-22 billion (sensitive to medical costs), medical loss ratio ~85-89%.

CNC and UNH are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CNC and UNH exposure against your real portfolio. It is not an investment adviser.